Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sensus Healthcare (SRTS) Gains from Investment Securities (2017 - 2026)

Sensus Healthcare has reported Gains from Investment Securities over the past 9 years, most recently at $814000.0 for Q4 2025.

  • For Q4 2025, Gains from Investment Securities rose 1212.9% year-over-year to $814000.0; the TTM value through Dec 2025 reached $1.4 million, up 154.96%, while the annual FY2025 figure was $1227.0, 85.61% down from the prior year.
  • Gains from Investment Securities for Q4 2025 was $814000.0 at Sensus Healthcare, up from $200223.0 in the prior quarter.
  • Over five years, Gains from Investment Securities peaked at $814000.0 in Q4 2025 and troughed at -$3.1 million in Q4 2022.
  • A 5-year average of $59201.6 and a median of $197723.0 in 2025 define the central range for Gains from Investment Securities.
  • Biggest five-year swings in Gains from Investment Securities: tumbled 6752.17% in 2022 and later surged 29547.3% in 2024.
  • Year by year, Gains from Investment Securities stood at $46000.0 in 2021, then tumbled by 6752.17% to -$3.1 million in 2022, then soared by 116.31% to $499000.0 in 2023, then plummeted by 87.58% to $62000.0 in 2024, then skyrocketed by 1212.9% to $814000.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for SRTS at $814000.0 in Q4 2025, $200223.0 in Q3 2025, and $200223.0 in Q2 2025.